Entry Point Capital, LLC Xencor Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Xencor Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 6,749 shares of XNCR stock, worth $109,198. This represents 0.19% of its overall portfolio holdings.
Number of Shares
6,749
Previous 14,306
52.82%
Holding current value
$109,198
Previous $317 Million
59.65%
% of portfolio
0.19%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$180 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$148 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$113 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$86.2 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$64.1 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $966M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...